As of Apr 25
| +1.27 / +1.94%|
The 14 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 56.50, with a high estimate of 74.00 and a low estimate of 43.00. The median estimate represents a -15.42% decrease from the last price of 66.80.
The current consensus among 17 polled investment analysts is to Hold stock in Seattle Genetics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.